Optics News

Johnson & Johnson introduced Acuvue Abiliti, a brand focused on creating products and services to help parents and eye care providers address the growing number of childhood myopia cases.

Investigators encouraged early multifocal lens intervention for patients nearing age 40 years despite finding no significant difference in comfort between multifocal and single lens wear, according to a study published in Ophthalmic and Physiological Optics.

Scleral contact lenses for the visual rehabilitation of patients with keratoconus were safe and efficacious, according to a record review published in Optometry and Vision Science.

The World Council of Optometry’s board of directors passed a resolution advising myopia management, mitigation and measurement to be incorporated as a standard of care for optometrists.

The Neurolens Measurement Device Gen 2 eye tracking system for measuring binocular vision is available for preorder in the U.S., announced the company in a press release.

Johnson & Johnson Vision announced the launch of Acuvue Oasys Multifocal with Pupil Optimized Design for patients with presbyopia.

CooperVision has partnered with the American Academy of Ophthalmology and the World Council of Optometry to address worldwide myopia and promote a standard of care for the disease, the company announced in recent press releases.

The Japanese Ministry of Health, Labour and Welfare approved Johnson & Johnson Vision’s Acuvue Theravision with Ketotifen, a drug-releasing combination contact lens designed for both vision correction and allergic eye itch relief.

A meta-analysis of the global incidence of amblyopia identified a prevalence rate of 1.44%, with an estimated increase to 221.9 million cases by the year 2040.

Children with accommodative esotropia experienced shifts in their degrees of hyperopia as they aged, according to a study.